Elizabeth A. Barrett

Insider Reports History

Identity 1 fact
Location
Ra'anana, Israel
SEC filing record 1 fact
SEC signature
/s/ Jason D. Smith, Attorney-in-Fact
SEC evidence 1 fact
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Elizabeth A. Barrett:

Form 4 holding Chief Executive Officer

UroGen Pharma Ltd.

Security class
Restricted Stock Units
Shares / value
153,195
Estimated value
Report date
31 Jan 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Chief Executive Officer

UroGen Pharma Ltd.

Security class
Performance Stock Units
Shares / value
87,615
Estimated value
Report date
28 Jul 2025
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Elizabeth A. Barrett

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .